Newron Pharmaceuticals

Newron Pharmaceuticals is a biopharmaceutical company focused on the discovery and development of drugs for the treatment of central nervous system disorders and pain. It develops Xadago, a New Chemical Entity (NCE) made for adjunctive therapy in Parkinson’s disease. Newron's pipeline also includes Sarizotan for patients with Rett syndrome and Ralfinamide for people with specific rare pain indications. In addition, the company develops Evenamide, an add-on therapy for the treatment of patients with positive symptoms of schizophrenia.